Home
Home

Savient

7 Biotechs Near 52-Week Lows

7 Biotechs Near 52-Week Lows
Motley Fool

5 Biotech Takeover / LBO Targets With Bullish Short Trends

5 Biotech Takeover / LBO Targets With Bullish Short Trends
Seeking Alpha

4 Biotech Stocks That Could Pop

4 Biotech Stocks That Could Pop
Seeking Alpha

Savient Pharma: Cheap Biotech Without FDA Approval Risk

Savient Pharma: Cheap Biotech Without FDA Approval Risk
Seeking Alpha

Top 15 Most Undervalued Biotech Stocks By Analyst Target Price

Top 15 Most Undervalued Biotech Stocks By Analyst Target Price
Seeking Alpha

News

Top Biotech Takeout Targets in 2011
Minyanville

News

Savient Closes Sale of $230 Million in Convertible Senior Notes
Yahoo/PR NewsWire

News

Savient Announces Proposed Offering of $125 Million in Convertible Senior Notes
Yahoo/PR NewsWire

News

Savient Names Lilly’s John Johnson Chief Executive
Bloomberg

News

Smart Money's 9 Top Biotech Stock Picks
Seeking Alpha